Improved Diagnosis of Ovarian Cancer

Sponsor
University of Aarhus (Other)
Overall Status
Recruiting
CT.gov ID
NCT05842629
Collaborator
Department of Gynaecology and Obstetrics, Aarhus University Hospital (Other), Department of Gynaecology and Obstetrics, Horsens Regional Hospital (Other), Department of Gynaecology and Obstetrics, Viborg Regional Hospital (Other), Department of Gynaecology and Obstetrics, Goedstrup Regional Hospital (Other), Department of Gynaecology and Obstetrics, Randers Regional Hospital (Other), Department of Clinical Medicine, Aarhus University (Other)
1,700
1
90.6
18.8

Study Details

Study Description

Brief Summary

After implementation of systematic image description of adnexal masses, we aim to improve and evaluate our use of available imaging methods and biomarkers for classifying adnexal masses and distinguishing between benign and malignant adnexal masses in the hands of clinicians in Central Denmark Region.

Secondarily, we want to improve our management of adnexal masses by evaluating the complications and longitudinal changes in conservatively managed adnexal masses.

Data is registered prospectively but analyzed retrospectively.

Detailed Description

Imaging methods include ultrasonography (US) by varied observers, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography-Computed Tomography (PET-CT).

Imaging criteria are based on recommendations by the International Ovarian Tumor Analysis (IOTA) group. Educational efforts in IOTA terminology and systematic description at ultrasonography may support quality in the diagnostic process.

Patients will be diagnosed and treated according to national and regional guidelines by the local clinicians.

The project has been evaluated by the Ethical Committee in the Central Denmark Region prior to initiation.

The aim of the power calculation for estimation of sample size is to be able to detect a difference in sensitivity from 75% to 90% at a threshold of 200 for Risk of Malignancy Index (RMI) and 10% for Assessment of Different NEoplasia of the adneXa (ADNEX) model and two-step-strategy / The Ovarian-Adnexal Reporting and Data System (O-RADS). To detect a difference in sensitivity (90% for ADNEX and two-step-strategy vs 75% for RMI at a specificity of 80%) at least 103 cases of malignancy should be included (calculated by using paired proportions).

Study Design

Study Type:
Observational
Anticipated Enrollment :
1700 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Improved Diagnosis of Ovarian Cancer
Actual Study Start Date :
May 15, 2021
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Dec 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Patients with an adnexal lesion in the Central Denmark Region

Outcome Measures

Primary Outcome Measures

  1. Diagnostic efficiency of available imaging modalities by models and subjective evaluation for pre-operative diagnosis of adnexal masses [6 months]

    Accuracy measures for diagnosis of ovarian cancer: Sensitivity, specificity, positive and negative predictive values.

  2. Area Under the Receiver Operating Characteristic Curve of ADNEX, O-RADS, two-step-strategy, Simple Rules and Risk of Malignancy Index. [6 months]

    Comparison of AUC's between models/strategies

Secondary Outcome Measures

  1. Longitudinal changes in adnexal masses [Up to 5 years]

    Change in imaging characteristics, occurrence of malignancy

  2. Complications in women with conservatively managed adnexal masses [Up to 5 years]

    Incidence of torsion, rupture, spontaneous resolution, surgeries.

  3. Observer variability [6 months]

    Inter- and intra observer variation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

Patients with an adnexal mass observed at ultrasonography.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Gynaecology and Obstetrics, Aarhus University Hospital Aarhus Denmark

Sponsors and Collaborators

  • University of Aarhus
  • Department of Gynaecology and Obstetrics, Aarhus University Hospital
  • Department of Gynaecology and Obstetrics, Horsens Regional Hospital
  • Department of Gynaecology and Obstetrics, Viborg Regional Hospital
  • Department of Gynaecology and Obstetrics, Goedstrup Regional Hospital
  • Department of Gynaecology and Obstetrics, Randers Regional Hospital
  • Department of Clinical Medicine, Aarhus University

Investigators

  • Principal Investigator: Ina Marie Dueholm Hjorth, MD, University of Aarhus
  • Study Director: Ole Mogensen, DMSci, University of Aarhus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ina Marie Dueholm Hjorth, Medical Doctor, PhD-student, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT05842629
Other Study ID Numbers:
  • adnexproject
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023